Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin - PubMed

Affiliations

• PMID: 20002307
• DOI: 10.1111/j.1365-2893.2009.01240.x

Prevalence of chronic viral hepatitis in people of south Asian ethnicity living in England: the prevalence cannot necessarily be predicted from the prevalence in the country of origin

G Uddin et al. J Viral Hepat. 2010 May.

Abstract

The prevalence of hepatitis B and hepatitis C in immigrant communities is unknown. Immigrants from south Asia are common in England and elsewhere, and the burden of viral hepatitis in these communities is unknown. We aimed to determine the prevalence of viral hepatitis in immigrants from south Asia living in England, and we therefore undertook a community-based testing project in such people at five sites in England. A total of 4998 people attending community centres were screened for viral hepatitis using oral fluid testing. The overall prevalence of anti-hepatitis C virus (HCV) in people of south Asian origin was 1.6% but varied by country of birth being 0.4%, 0.2%, 0.6% and 2.7% in people of this ethnic group born in the UK, India, Bangladesh and Pakistan, respectively. The prevalence of hepatitis B surface antigen was 1.2%-0.2%, 0.1%, 1.5% and 1.8% in people of this ethnic group born in the UK, India, Bangladesh and Pakistan, respectively. Analysis of risk factors for HCV infection shows that people from the Pakistani Punjab and those who have immigrated recently are at increased risk of infection. Our study suggests that migrants from Pakistan are at highest risk of viral hepatitis, with those from India at low risk. As prevalence varies both by country and region of origin and over time, the prevalence in migrant communities living in western countries cannot be easily predicted from studies in the country of origin.

Similar articles

• Targeted case finding for hepatitis B using dry blood spot testing in the British-Chinese and South Asian populations of the North-East of England.

  McPherson S, Valappil M, Moses SE, Eltringham G, Miller C, Baxter K, Chan A, Shafiq K, Saeed A, Qureshi R, Hudson M, Bassendine MF. McPherson S, et al. J Viral Hepat. 2013 Sep;20(9):638-44. doi: 10.1111/jvh.12084. Epub 2013 Mar 12. J Viral Hepat. 2013. PMID: 23910648

• High prevalence of hepatitis markers in immigrant populations: a prospective screening approach in a real-world setting.

  Heidrich B, Cetindere A, Beyaz M, Stahmeyer JT, Basaran MM, Braynis B, Raupach R, Bremer B, Manns MP, Wedemeyer H, Bastürk M. Heidrich B, et al. Eur J Gastroenterol Hepatol. 2014 Oct;26(10):1090-7. doi: 10.1097/MEG.0000000000000164. Eur J Gastroenterol Hepatol. 2014. PMID: 25076065

• The prevalence of hepatitis C virus among people of South Asian origin in Glasgow - results from a community based survey and laboratory surveillance.

  O'Leary MC, Sarwar M, Hutchinson SJ, Weir A, Schofield J, McLeod A, Cameron S, McTaggart C, Banday S, Foster GR, Ahmed S, Fox R, Mills PR, Goldberg DJ, Anderson E. O'Leary MC, et al. Travel Med Infect Dis. 2013 Sep-Oct;11(5):301-9. doi: 10.1016/j.tmaid.2013.08.001. Epub 2013 Aug 23. Travel Med Infect Dis. 2013. PMID: 24007935

• [Chronic viral hepatitis B and C in immigrant population, Spain].

  Calderón Sandubete E, Yang Lai R, Calero Bernal ML, Martínez Rísquez MT, Calderón Baturone M, Horra Padilla Cde L. Calderón Sandubete E, et al. Rev Esp Salud Publica. 2014 Nov-Dec;88(6):811-8. doi: 10.4321/S1135-57272014000600012. Rev Esp Salud Publica. 2014. PMID: 25418570 Review. Spanish.

• Hepatitis B and C.

  Mysore KR, Leung DH. Mysore KR, et al. Clin Liver Dis. 2018 Nov;22(4):703-722. doi: 10.1016/j.cld.2018.06.002. Epub 2018 Aug 22. Clin Liver Dis. 2018. PMID: 30266158 Review.

Cited by

• Outcomes of hepatitis C screening programs targeted at risk groups hidden in the general population: a systematic review.

  Zuure FR, Urbanus AT, Langendam MW, Helsper CW, van den Berg CH, Davidovich U, Prins M. Zuure FR, et al. BMC Public Health. 2014 Jan 22;14:66. doi: 10.1186/1471-2458-14-66. BMC Public Health. 2014. PMID: 24450797 Free PMC article. Review.

• Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016.

  Bundle N, Balasegaram S, Parry S, Ullah S, Harris RJ, Ahmad K, Foster GR, Tong CY, Orkin C. Bundle N, et al. Euro Surveill. 2019 Jul;24(27):1800377. doi: 10.2807/1560-7917.ES.2019.24.27.1800377. Euro Surveill. 2019. PMID: 31290390 Free PMC article.

• Limited access to hepatitis B/C treatment among vulnerable risk populations: an expert survey in six European countries.

  Falla AM, Veldhuijzen IK, Ahmad AA, Levi M, Hendrik Richardus J. Falla AM, et al. Eur J Public Health. 2017 Apr 1;27(2):302-306. doi: 10.1093/eurpub/ckw100. Eur J Public Health. 2017. PMID: 27542982 Free PMC article.

• Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes.

  Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Petruzziello A, et al. World J Gastroenterol. 2016 Sep 14;22(34):7824-40. doi: 10.3748/wjg.v22.i34.7824. World J Gastroenterol. 2016. PMID: 27678366 Free PMC article. Review.

• Hepatitis B virus: where do we stand and what is the next step for eradication?

  Komatsu H. Komatsu H. World J Gastroenterol. 2014 Jul 21;20(27):8998-9016. doi: 10.3748/wjg.v20.i27.8998. World J Gastroenterol. 2014. PMID: 25083074 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Research Materials

  • NCI CPTC Antibody Characterization Program